Medartis Holding AG
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDRSF research report →
Companywww.medartis.com
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names.
- CEO
- Matthias Schupp
- IPO
- 2020
- Employees
- 816
- HQ
- Basel, CH
Price Chart
Valuation
- Market Cap
- $1.43B
- P/E
- 117.04
- P/S
- 3.63
- P/B
- 3.54
- EV/EBITDA
- 43.05
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 75.89%
- Op Margin
- 0.42%
- Net Margin
- 3.10%
- ROE
- 3.11%
- ROIC
- 0.16%
Growth & Income
- Revenue
- $269.26M · 19.76%
- Net Income
- $8.35M · 136.65%
- EPS
- $0.67 · 157.69%
- Op Income
- $1.93M
- FCF YoY
- -55.47%
Performance & Tape
- 52W High
- $115.00
- 52W Low
- $66.68
- 50D MA
- $115.00
- 200D MA
- $95.45
- Beta
- 1.20
- Avg Volume
- 3
Get TickerSpark's AI analysis on MDRSF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MDRSF Coverage
We haven't published any research on MDRSF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MDRSF Report →